Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Study to Investigate the Effect of Bupivacaine Liposomal Injectable Suspension on Hospital Costs, Length of Stay, and Discharge Status in Patients Undergoing Total Knee Arthroplasty at High Use Institutions

Trial Profile

A Study to Investigate the Effect of Bupivacaine Liposomal Injectable Suspension on Hospital Costs, Length of Stay, and Discharge Status in Patients Undergoing Total Knee Arthroplasty at High Use Institutions

Completed
Phase of Trial: Phase IV

Latest Information Update: 09 Dec 2018

At a glance

  • Drugs Bupivacaine (Primary)
  • Indications Postoperative pain
  • Focus Therapeutic Use
  • Most Recent Events

    • 09 Dec 2018 New trial record
    • 27 Nov 2018 According to a Pacira Pharmaceuticals media release, results of this study were published in The Journal of Medical Economics.
    • 27 Nov 2018 New results from this study presented in a Pacira Pharmaceuticals media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top